Document is current
Any future updates will be listed below
-
Authors
Gargett, Tessa https://orcid.org/0000-0003-3713-1373
Abbas, M. Nazim
Rolan, Paul
Price, Jason D.
Gosling, Katharine M.
Ferrante, Antonio
Ruszkiewicz, Andrew
Atmosukarto, Ines I. C.
Altin, Joseph
Parish, Christopher R.
Brown, Michael P.
- License Information
-
More Information
Article History
Received: 14 August 2017
Accepted: 9 July 2018
First Online: 16 July 2018
Compliance with ethical standards
:
: Jason D. Price, Katharine M. Gosling, and Ines I.C. Atmosukarto are employed by Lipotek Pty Ltd. Paul Rolan, Joseph Altin, and Christopher R. Parish are Lipotek shareholders. Paul Rolan and Ines I.C. Atmosukarto are Directors of Lipotek. All other authors declare that they have no conflict of interest.
: The Royal Adelaide Hospital Human Research Ethics Committee provided specific written approval of the Clinical Protocol and its subsequent amendments before participants were enrolled to the study (RAH Protocol No: 081124). This study was performed in accordance with the Therapeutic Goods Administration (TGA) Note for Guidance on Good Clinical Practice (2000), the ethical rules contained in the National Statement on Ethical Conduct in Human Research (2007) and the Declaration of Helsinki (1964). The trial was registered with the Australia and New Zealand Clinical Trials Registry (ACTRN12610000149066).
: Informed written consent was obtained from all patients before enrollment.
